Knowledge

Giorgio Walter Canonica

Source đź“ť

31: 301:
Grattan, C.; Hebert, J.; Hide, M.; Kaplan, A.; Kapp, A.; Katelaris, C. H.; Kocatürk, E.; Kulthanan, K.; Larenas-Linnemann, D.; Leslie, T. A.; Magerl, M.; Mathelier-Fusade, P.; Meshkova, R. Y.; Metz, M.; Nast, A.; Nettis, E.; Oude-Elberink, H.; Rosumeck, S.; Saini, S. S.; Sánchez-Borges, M.; Schmid-Grendelmeier, P.; Staubach, P.; Sussman, G.; Toubi, E.; Vena, G. A.; Vestergaard, C.; Wedi, B.; Werner, R. N.; Zhao, Z.; Maurer, M. (July 2018).
401:
Canonica, G. W.; Baena-Cagnani, C. E.; Bousquet, J.; Bousquet, P. J.; Lockey, R. F.; Malling, H.-J.; Passalacqua, G.; Potter, P.; Valovirta, E. (8 February 2007). "Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a
300:
Zuberbier, T.; Aberer, W.; Asero, R.; Abdul Latiff, A. H.; Baker, D.; Ballmer-Weber, B.; Bernstein, J. A.; Bindslev-Jensen, C.; Brzoza, Z.; Buense Bedrikow, R.; Canonica, G. W.; Church, M. K.; Craig, T.; Danilycheva, I. V.; Dressler, C.; Ensina, L. F.; Giménez-Arnau, A.; Godse, K.; Gonçalo, M.;
193:
Canonica returned to Genoa University in 1995 and served at different positions including the full professor Internal Medicine and Pulmonary Medicine, Director of the Speciality School of Allergy and Clinical Immunology, Director of the Specialty School of Pulmonary Diseases, Chairman of the
961: 346:
BroĹĽek, Jan L.; Bousquet, Jean; Baena-Cagnani, Carlos E.; Bonini, Sergio; Canonica, G. Walter; Casale, Thomas B.; van Wijk, Roy Gerth; Ohta, Ken; Zuberbier, Torsten; SchĂĽnemann, Holger J. (September 2010).
134:
at Humanitas Research Hospital IRCCS-Milano Italy since December 2016. He is known for his research work related to innovative treatment strategies for allergic diseases which includes
1011: 199: 207: 743: 563: 255:(GINA). Canonica is one of the steering committee members of Severe Asthma Network Italy registry (SANI) and member of European Academy of Sciences 1106: 767:
Rossi, Oliviero; Massaro, Ilaria; Caminati, Marco; Quecchia, Cristina; Fassio, Filippo; Heffler, Enrico; Canonica, Giorgio Walter (2015-08-04).
150:
for six consecutive years and has served as president of the same organization during 2007–09. He is also the vice-president of INTERASMA.
656:"Giorgio Walter Canonica - Professor of Pediatrics Allergy and Immunology, Respiratory Therapy in Genova, Liguria, Italy | eMedEvents" 1101: 453:
Varricchi, Gilda; Senna, Gianenrico; Loffredo, Stefania; Bagnasco, Diego; Ferrando, Matteo; Canonica, Giorgio Walter (2017).
856: 179: 84: 278:
and airway remodeling. He is also known to be involved in innovative treatment strategies for allergic diseases including
266:
Canonica's research areas primarily include the observations of molecular events, which further includes interactivity of
1051: 826: 348: 1052:"Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)" 303:"The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria" 279: 135: 215: 147: 96: 719: 655: 1072: 287: 174:. Consequently, he carried out research works in clinical immunology and allergology research from 143: 402:
World Allergy Organization (WAO) taskforce: Recommendations for immunotherapy clinical trials".
1091: 937: 882:"History of the World Allergy Organization: Two Decades Leading to World Leadership, 1990-2010" 631: 986: 275: 539: 1096: 123: 92: 8: 512: 171: 163: 159: 67: 1033: 914: 881: 803: 768: 489: 454: 427: 389: 175: 88: 1012:"COVID-19 Pandemic Allergen specific Immunotherapy Positioning in Respiratory Allergy" 1037: 919: 901: 838: 808: 790: 744:"Expertise in Asthma: Giorgio Walter Canonica - Interasma's Chief Executive Director" 701: 564:"Expertise in Asthma: Giorgio Walter Canonica - Interasma's Chief Executive Director" 494: 476: 419: 415: 381: 334: 271: 431: 1023: 909: 893: 798: 780: 691: 484: 466: 411: 371: 363: 324: 314: 267: 166:. He then moved to Florence University while keeping the primary specialization in 393: 194:
Department of Medical Specialties (University Hospital San Martino Genoa, Italy),
897: 696: 679: 195: 1076: 1028: 367: 962:"Canonica G. Walter, Professor of Respiratory Diseases and Allergy - Director" 785: 1085: 905: 842: 794: 705: 480: 471: 349:"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision" 283: 139: 455:"Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?" 923: 812: 498: 423: 385: 338: 162:
during 1972. He started his career as a specialist in pulmonary disease at
614: 30: 590: 329: 376: 319: 302: 400: 119: 115: 146:(SLIT). He has served as Secretary General and President elect of 345: 203: 167: 299: 158:
Canonica received his master's degree from School of Medicine,
452: 127: 766: 225:
Italian Society of Allergy, Asthma and Clinical Immunology
206:
etc.. He is also currently serving as Editor in chief of
231:(SIMeR). He is presently serving as the ExCom Member of 243:(GA²LEN). He is also working as the Vice-president of 857:"Professor G. Walter Canonica, MD | The AIT Network" 831:Current Opinion in Allergy and Clinical Immunology 684:Current Opinion in Allergy and Clinical Immunology 208:Current Opinion in Allergy and Clinical Immunology 132:Personalized Medicine Asthma & Allergy Center 1083: 213:Previously, Canonica worked as the president of 241:Global Allergy & Asthma Excellence Network 938:"Academy of Europe - Giorgio Walter Canonica" 540:"Academy of Europe: Canonica Giorgio Walter" 153: 591:"SRxA | Professor Giorgio Walter Canonica" 356:Journal of Allergy and Clinical Immunology 233:Allergic Rhinitis and its Impact on Asthma 29: 1027: 913: 802: 784: 695: 488: 470: 375: 328: 318: 1009: 769:"Escaping the trap of allergic rhinitis" 1016:US Respiratory & Pulmonary Diseases 1010:Canonica, Giorgio Walter (2020-11-25). 879: 293: 237:Collegium Internationale Allergologicum 229:Italian Society of Respiratory Medicine 1107:Academic staff of Humanitas University 1084: 180:Medical University of South Carolina, 100:Global Asthma Association (INTERASMA) 984: 585: 583: 534: 532: 85:Medical University of South Carolina 720:"Professor Giorgio Walter Canonica" 251:(EAACI), International advocate of 16:Italian allergist and pulmonologist 13: 1056:SANI (Severe Asthma Network Italy) 886:World Allergy Organization Journal 880:Kaliner, Michael A. (2011-01-01). 615:"Resume - Giorgio Walter Canonica" 14: 1118: 580: 529: 261: 68:University of Genoa, Milan, Italy 416:10.1111/j.1398-9995.2006.01312.x 1102:21st-century Italian physicians 1044: 1003: 987:"Science Committee | EAACI.org" 978: 954: 930: 873: 849: 819: 760: 736: 712: 245:Respiratory Effectiveness Group 773:Clinical and Molecular Allergy 672: 648: 624: 607: 556: 505: 446: 114:(Born October 25, 1947) is an 1: 439: 274:and immunocompetent cells in 176:University of Uppsala, Sweden 118:allergist, pulmonologist and 898:10.1097/WOX.0b013e31823ba552 697:10.1097/ACI.0b013e328324b654 280:biological response modifier 136:biological response modifier 7: 1066: 124:Humanitas University, Milan 122:of Respiratory Medicine at 93:Humanitas University, Milan 10: 1123: 1029:10.17925/USPRD.2020.5.1.10 368:10.1016/j.jaci.2010.06.047 216:World Allergy Organization 148:World Allergy Organisation 97:World Allergy Organization 827:"Editorial introductions" 786:10.1186/s12948-015-0023-y 680:"Editorial introductions" 513:"Giorgio Walter Canonica" 286:with primary emphasis on 249:the Methodology Committee 235:(ARIA), board members of 221:Global Asthma Association 188: 142:with primary emphasis on 105: 80: 73: 63: 55: 40: 28: 21: 1075:publications indexed by 472:10.3389/fimmu.2017.00242 288:sublingual immunotherapy 253:Global Asthma InitiAtive 200:Cluji Medical University 154:Early life and education 144:sublingual immunotherapy 1073:Giorgio Walter Canonica 985:Kostaras, Charalampos. 837:(1): i. February 2004. 632:"Academy of Europe: CV" 459:Frontiers in Immunology 112:Giorgio Walter Canonica 35:Giorgio Walter Canonica 23:Giorgio Walter Canonica 861:www.theaitnetwork.com 276:allergic inflammation 294:Notable publications 282:in form of targeted 196:Laurea Honoris Causa 138:in form of targeted 172:Clinical Immunology 164:University of Genoa 160:University of Genoa 690:(1): vii–x. 2009. 660:www.emedevents.com 272:inflammatory cells 89:Uppsala University 320:10.1111/all.13397 109: 108: 75:Scientific career 1114: 1060: 1059: 1048: 1042: 1041: 1031: 1007: 1001: 1000: 998: 997: 982: 976: 975: 973: 972: 958: 952: 951: 949: 948: 934: 928: 927: 917: 877: 871: 870: 868: 867: 853: 847: 846: 823: 817: 816: 806: 788: 764: 758: 757: 755: 754: 740: 734: 733: 731: 730: 716: 710: 709: 699: 676: 670: 669: 667: 666: 652: 646: 645: 643: 642: 628: 622: 621: 619: 611: 605: 604: 602: 601: 587: 578: 577: 575: 574: 560: 554: 553: 551: 550: 536: 527: 526: 524: 523: 509: 503: 502: 492: 474: 450: 435: 397: 379: 353: 342: 332: 322: 313:(7): 1393–1414. 268:epithelial cells 247:(REG), Chair of 51:October 25, 1947 50: 48: 33: 19: 18: 1122: 1121: 1117: 1116: 1115: 1113: 1112: 1111: 1082: 1081: 1069: 1064: 1063: 1050: 1049: 1045: 1008: 1004: 995: 993: 983: 979: 970: 968: 966:lung-health.org 960: 959: 955: 946: 944: 942:www.ae-info.org 936: 935: 931: 892:(11): 231–248. 878: 874: 865: 863: 855: 854: 850: 825: 824: 820: 765: 761: 752: 750: 742: 741: 737: 728: 726: 718: 717: 713: 678: 677: 673: 664: 662: 654: 653: 649: 640: 638: 636:www.ae-info.org 630: 629: 625: 617: 613: 612: 608: 599: 597: 589: 588: 581: 572: 570: 562: 561: 557: 548: 546: 544:www.ae-info.org 538: 537: 530: 521: 519: 511: 510: 506: 451: 447: 442: 351: 296: 264: 191: 182:Charleston, USA 156: 101: 99: 95: 91: 87: 64:Alma mater 46: 44: 36: 24: 17: 12: 11: 5: 1120: 1110: 1109: 1104: 1099: 1094: 1080: 1079: 1077:Google Scholar 1068: 1065: 1062: 1061: 1043: 1002: 977: 953: 929: 872: 848: 818: 759: 735: 711: 671: 647: 623: 606: 579: 555: 528: 504: 444: 443: 441: 438: 437: 436: 410:(3): 317–324. 398: 362:(3): 466–476. 343: 295: 292: 263: 262:Research areas 260: 190: 187: 155: 152: 107: 106: 103: 102: 82: 78: 77: 71: 70: 65: 61: 60: 57: 53: 52: 42: 38: 37: 34: 26: 25: 22: 15: 9: 6: 4: 3: 2: 1119: 1108: 1105: 1103: 1100: 1098: 1095: 1093: 1092:Living people 1090: 1089: 1087: 1078: 1074: 1071: 1070: 1057: 1053: 1047: 1039: 1035: 1030: 1025: 1021: 1017: 1013: 1006: 992: 991:www.eaaci.org 988: 981: 967: 963: 957: 943: 939: 933: 925: 921: 916: 911: 907: 903: 899: 895: 891: 887: 883: 876: 862: 858: 852: 844: 840: 836: 832: 828: 822: 814: 810: 805: 800: 796: 792: 787: 782: 778: 774: 770: 763: 749: 748:GAA Interasma 745: 739: 725: 724:www.aminer.cn 721: 715: 707: 703: 698: 693: 689: 685: 681: 675: 661: 657: 651: 637: 633: 627: 616: 610: 596: 592: 586: 584: 569: 568:GAA Interasma 565: 559: 545: 541: 535: 533: 518: 514: 508: 500: 496: 491: 486: 482: 478: 473: 468: 464: 460: 456: 449: 445: 433: 429: 425: 421: 417: 413: 409: 405: 399: 395: 391: 387: 383: 378: 373: 369: 365: 361: 357: 350: 344: 340: 336: 331: 326: 321: 316: 312: 308: 304: 298: 297: 291: 289: 285: 284:immunotherapy 281: 277: 273: 269: 259: 258: 254: 250: 246: 242: 238: 234: 230: 227:(SIAAIC) and 226: 223:(INTERASMA), 222: 218: 217: 211: 209: 205: 201: 197: 186: 184: 183: 177: 173: 169: 165: 161: 151: 149: 145: 141: 140:immunotherapy 137: 133: 130:and Director 129: 125: 121: 117: 113: 104: 98: 94: 90: 86: 83: 79: 76: 72: 69: 66: 62: 58: 54: 43: 39: 32: 27: 20: 1055: 1046: 1019: 1015: 1005: 994:. Retrieved 990: 980: 969:. Retrieved 965: 956: 945:. Retrieved 941: 932: 889: 885: 875: 864:. Retrieved 860: 851: 834: 830: 821: 776: 772: 762: 751:. Retrieved 747: 738: 727:. Retrieved 723: 714: 687: 683: 674: 663:. Retrieved 659: 650: 639:. Retrieved 635: 626: 609: 598:. Retrieved 595:www.srxa.com 594: 571:. Retrieved 567: 558: 547:. Retrieved 543: 520:. Retrieved 516: 507: 462: 458: 448: 407: 403: 359: 355: 310: 306: 265: 256: 252: 248: 244: 240: 236: 232: 228: 224: 220: 214: 212: 192: 181: 157: 131: 111: 110: 81:Institutions 74: 1097:1947 births 330:10230/35554 56:Citizenship 1086:Categories 996:2021-07-05 971:2021-07-05 947:2021-07-05 866:2021-07-05 753:2021-07-05 729:2021-07-05 665:2020-10-13 641:2020-10-13 600:2020-10-13 573:2020-10-13 549:2020-10-13 522:2020-10-13 440:References 377:1822/49100 239:(CIA) and 47:1947-10-25 1038:234941178 906:1939-4551 843:1528-4050 795:1476-7961 779:(1): 17. 706:1528-4050 481:1664-3224 120:professor 1067:See also 924:23268440 813:26244040 499:28344579 432:16237704 424:17298350 386:20816182 339:29336054 290:(SLIT). 915:3488903 804:4524393 517:Hunimed 490:5344894 465:: 242. 404:Allergy 307:Allergy 219:(WAO), 204:Romania 168:Allergy 116:Italian 59:Italian 1036:  1022:: 10. 922:  912:  904:  841:  811:  801:  793:  704:  497:  487:  479:  430:  422:  394:536060 392:  384:  337:  189:Career 1034:S2CID 618:(PDF) 428:S2CID 390:S2CID 352:(PDF) 128:Italy 920:PMID 902:ISSN 839:ISSN 809:PMID 791:ISSN 702:ISSN 495:PMID 477:ISSN 420:PMID 382:PMID 335:PMID 178:and 170:and 41:Born 1024:doi 910:PMC 894:doi 799:PMC 781:doi 692:doi 485:PMC 467:doi 412:doi 372:hdl 364:doi 360:126 325:hdl 315:doi 185:. 1088:: 1054:. 1032:. 1018:. 1014:. 989:. 964:. 940:. 918:. 908:. 900:. 888:. 884:. 859:. 833:. 829:. 807:. 797:. 789:. 777:13 775:. 771:. 746:. 722:. 700:. 686:. 682:. 658:. 634:. 593:. 582:^ 566:. 542:. 531:^ 515:. 493:. 483:. 475:. 461:. 457:. 426:. 418:. 408:62 406:. 388:. 380:. 370:. 358:. 354:. 333:. 323:. 311:73 309:. 305:. 270:, 210:. 202:, 198:, 126:, 1058:. 1040:. 1026:: 1020:5 999:. 974:. 950:. 926:. 896:: 890:4 869:. 845:. 835:4 815:. 783:: 756:. 732:. 708:. 694:: 688:9 668:. 644:. 620:. 603:. 576:. 552:. 525:. 501:. 469:: 463:8 434:. 414:: 396:. 374:: 366:: 341:. 327:: 317:: 257:. 49:) 45:(

Index


University of Genoa, Milan, Italy
Medical University of South Carolina
Uppsala University
Humanitas University, Milan
World Allergy Organization
Italian
professor
Humanitas University, Milan
Italy
biological response modifier
immunotherapy
sublingual immunotherapy
World Allergy Organisation
University of Genoa
University of Genoa
Allergy
Clinical Immunology
University of Uppsala, Sweden
Medical University of South Carolina, Charleston, USA
Laurea Honoris Causa
Cluji Medical University
Romania
Current Opinion in Allergy and Clinical Immunology
World Allergy Organization
epithelial cells
inflammatory cells
allergic inflammation
biological response modifier
immunotherapy

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑